Gianluca Pirozzi
Direktor/Vorstandsmitglied bei TREX WIND-DOWN, INC.
Vermögen: 1 $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ed Sitar | M | 63 | 4 Jahre | |
| Sean Christie | M | - | 3 Jahre | |
| Lubor Gaal | M | 56 | 4 Jahre | |
| Piyush Sharma | M | - | 7 Jahre | |
| David Cohen | M | 59 | 4 Jahre | |
| Sarah Marshall | F | - | 10 Jahre | |
| Christophe Hotermans | M | - | 4 Jahre | |
| Ruth Diazaraque | M | - | 1 Jahre | |
| Seng Cheng | M | - | 1 Jahre | |
| Jessica Bruno-Raiz | F | - | 5 Jahre | |
| Glen Frick | M | 57 | - | |
| Nicola Heffron | F | 52 | 1 Jahre | |
| Morgan Sanford | F | - | - | |
| Tamar Thompson | F | 50 | 5 Jahre | |
| Patryk Mikucki | M | 49 | - | |
| Frédéric Chéreau | M | 57 | 2 Jahre | |
| Marc Dunoyer | M | 71 | - | |
| Todd Spalding | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Brennan | M | 70 | 7 Jahre | |
| Zachary Rome | M | 40 | 2 Jahre | |
| John Koconis | M | 54 | 4 Jahre | |
| Joe Lucchese | M | 57 | 4 Jahre | |
| Felix Baker | M | 55 | 6 Jahre | |
| Rana Strellis | F | - | 4 Jahre | |
| Christopher Coughlin | M | 71 | 7 Jahre | |
| Susan Altschuller | M | 42 | 2 Jahre | |
| Michael T. Stocum | M | 58 | - | |
| Scott Peters | M | - | 8 Jahre | |
| Michael Ira Kenneth Elloian | M | 52 | - | |
| Ludwig Hantson | M | 61 | 4 Jahre | |
| Ebun Garner | M | 52 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 Jahre |
| Jack Mollen | M | 73 | 7 Jahre | |
| Brian Goff | M | 55 | 4 Jahre | |
| Judith Reinsdorf | F | 60 | 3 Jahre | |
| Paul Friedman | M | 81 | 4 Jahre | |
| Anne-Marie Law | F | 56 | 3 Jahre | |
| Ellen Chiniara | F | 65 | 3 Jahre | |
| Francois Nader | M | 67 | 4 Jahre | |
| Deborah Dunsire | M | 61 | 3 Jahre | |
| Linda A. Broenniman | F | 67 | - | |
| Andreas Rummelt | M | 66 | 11 Jahre | |
| Thierry Chauche | M | 48 | 1 Jahre | |
| Ai Min Hui | M | 61 |
Sanofi SA
| 2 Jahre |
| Angela Giannantonio | F | - | - | |
| Shane Doyle | M | - | 7 Jahre | |
| Megan Goulart | F | - | - | |
| Kristen Stants | F | 51 | 2 Jahre | |
| Adam Hansard | M | 48 | 1 Jahre | |
| Christopher Wick | M | - | 4 Jahre | |
| Alexandra Kropotova | M | 51 |
Sanofi SA
| 9 Jahre |
| Christopher Sorli | M | - |
Sanofi SA
| 4 Jahre |
| Uzair Qadeer | M | - | 2 Jahre | |
| Becky Lillie | F | - | - | |
| Rosemary Harrison | M | 41 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 Jahre |
| Alan Mendelsohn | M | 62 | 3 Jahre | |
| Julia Wang | F | 53 | 2 Jahre | |
| Martine Zimmermann | M | 55 | 7 Jahre | |
| Holly Schachner | M | 57 |
Sanofi SA
| 5 Jahre |
| Sandra Jonsson | M | 51 | - | |
| Christopher Benecchi | M | - | 2 Jahre | |
| Michael Lisjak | M | 50 |
Sanofi SA
| 1 Jahre |
| Patrick Barry | M | - |
Sanofi SA
| 24 Jahre |
| Ann Miller | M | 66 |
Sanofi SA
| 6 Jahre |
| Amir Tavakkol | M | 69 | 1 Jahre | |
| Paul Sekhri | M | 65 |
Sanofi SA
| 1 Jahre |
| Heidi Henson | F | 58 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 Jahre |
| Laurie Keating | F | 70 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 Jahre |
| Christopher J. Stevo | M | - | 1 Jahre | |
| Michael Derby | M | 51 | 2 Jahre | |
| Paul Clancy | M | 62 | 2 Jahre | |
| Emmanuel Babeau | M | 57 |
Sanofi SA
| 2 Jahre |
| Steven M. Bosacki | M | 66 | - | |
| Tanisha Cariño | M | 49 | 2 Jahre | |
| Indrani Franchini | F | 52 | 4 Jahre | |
| H. Cohen | M | 58 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | - |
| John V. W. Reynders | M | - | 6 Jahre | |
| Vincent O'Neill | M | 55 |
Sanofi SA
| 2 Jahre |
| John Orloff | M | 66 | 4 Jahre | |
| Dieter Weinand | M | 63 |
Sanofi SA
| 2 Jahre |
| Jose Menoyo | M | - | 3 Jahre | |
| Desiree Luthman | M | 65 |
Sanofi SA
| 2 Jahre |
| Ching Jaw | M | 61 |
Sanofi SA
| 2 Jahre |
| Michael Kaseta | M | 48 |
Sanofi SA
| 11 Jahre |
| Daniel A. Bazarko | M | - | 9 Jahre | |
| Tsveta Milanova | F | 47 | 2 Jahre | |
| Laura Gault | F | - | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 72 | 83,72% |
| Frankreich | 14 | 16,28% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gianluca Pirozzi
- Persönliches Netzwerk
